CYTEIR THERAPEUTICS INC (CYT)

US23284P1030 - Common Stock

3.02  -0.07 (-2.27%)

After market: 3.1 +0.08 (+2.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.0010.00K
Operating Expenses
33.95M48.17M42.26M20.94M16.11M
Research and Development
21.75M33.59M30.96M16.77M12.77M
Selling, General, and Administrative Expenses
12.20M14.58M11.30M4.18M3.35M
Operating Income
-33.95M-48.17M-42.26M-20.94M-16.11M
Interest Income/Expense
N/AN/AN/A0.00820.00K
Other Income/Expense
N/A2.11M130.00K120.00K250.00K
Income Before Taxes
-33.21M-46.06M-42.13M-20.82M-15.04M
Net Income
-33.21M-46.06M-42.13M-20.82M-15.04M
EBITDA
-33.41M-47.50M-41.78M-20.59M-15.89M
 
Per Share Data
EPS Diluted Total Ops
-0.94-1.31-1.20-0.60-0.44
Non GAAP EPS
N/A-1.30N/AN/AN/A
 
Statistics
Profit Margin
N/AN/AN/AN/A-150400.00%
Operating Profit Margin
N/AN/AN/AN/A-161100.00%

All data in USD

Charts